Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – What’s Next?

Fresenius SE & Co. (OTCMKTS:FSNUY)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $12.10, but opened at $12.63. Fresenius SE & Co. shares last traded at $12.7068, with a volume of 1,645 shares changing hands.

Analyst Ratings Changes

Separately, Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Fresenius SE & Co. has a consensus rating of “Buy”.

Fresenius SE & Co. Stock Performance

The company has a debt-to-equity ratio of 0.41, a current ratio of 1.27 and a quick ratio of 0.98. The stock has a 50-day moving average price of $11.42 and a 200-day moving average price of $13.04. The firm has a market capitalization of $27.49 billion, a PE ratio of 16.27 and a beta of 0.63.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The business had revenue of $6.75 billion during the quarter, compared to analysts’ expectations of $6.79 billion. On average, research analysts expect that Fresenius SE & Co. will post 1.03 EPS for the current fiscal year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.